论文部分内容阅读
目的探讨剖宫产瘢痕妊娠48例患者不同治疗方法的临床疗效。方法回顾性分析我院妇科病房2012年9月至2014年3月收治的48例剖宫产瘢痕妊娠患者诊治资料,根据治疗方法的不同分为将患者两组。A组患者给予甲氨蝶呤(MTX)+米非司酮+清宫术治疗;B组患者给予子宫动脉栓塞术(UAE)联合MTX灌注化疗及清宫术治疗。比较两组患者的治疗效果。结果 A组和B组患者的治疗成功率分别为75.0%(15/20)、96.4%(27/28),两组比较差异有统计学意义(P<0.05)。B组患者住院时间、术后血人绒毛膜促性腺激素(HCG)转阴时间最短,与A组比较差异有统计学意义(P<0.05)。结论 UAE联合MTX灌注化疗及清宫术治疗剖宫产瘢痕妊娠患者效果良好,并发症少,术后恢复快,不良反应低。
Objective To investigate the curative effect of different treatment methods in 48 patients with cesarean scar pregnancy. Methods A retrospective analysis of our hospital gynecology ward admitted to September 2012 to March 2014 in 48 cases of cesarean scar pregnancy diagnosis and treatment of patients according to the different treatment methods will be divided into two groups of patients. Patients in group A were treated with methotrexate (MTX) and mifepristone plus curettage. Patients in group B received uterine arterial embolization (UAE) combined with MTX perfusion chemotherapy and curettage. The treatment effect of two groups of patients was compared. Results The success rates of treatment in group A and group B were 75.0% (15/20) and 96.4% (27/28), respectively. The difference between the two groups was statistically significant (P <0.05). The hospitalization time of patients in group B was the shortest, and the difference was statistically significant (P <0.05). Conclusion UAE combined with MTX chemotherapy and cesarean section in cesarean scar pregnancy patients with good results, fewer complications, fast recovery, adverse reactions.